Federica Zanca’s Post

👏 #𝐒𝐰𝐢𝐬𝐬𝐌𝐞𝐝𝐓𝐞𝐜𝐡E𝐱𝐩𝐨 2025 left a strong impression of an industry that is maturing fast and shaping smarter ways to serve patients and clinicians. Here are some of the technologies that stood out on the floor: 🔧 𝐀𝐝𝐝𝐢𝐭𝐢𝐯𝐞 𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐫𝐞𝐚𝐝𝐲 𝐟𝐨𝐫 𝐩𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧 – 3D-printed surgical guides, housings, and connectors with validated quality and regulatory compliance, now used in routine manufacturing. 🤖 𝐀𝐈 𝐚𝐩𝐩𝐥𝐢𝐞𝐝 𝐰𝐡𝐞𝐫𝐞 𝐢𝐭 𝐦𝐚𝐭𝐭𝐞𝐫𝐬 – signal analysis, risk alerts, and automated documentation built directly into clinical workflows to support faster, safer decisions. 📏 𝐄𝐱𝐭𝐫𝐞𝐦𝐞 𝐦𝐢𝐧𝐢𝐚𝐭𝐮𝐫𝐢𝐳𝐚𝐭𝐢𝐨𝐧 – complete medical-grade electronics assemblies shrunk to palm-sized modules, enabling lighter, more portable systems for use at the point of care. As Marc Nagel put it: “𝑻𝒘𝒆𝒏𝒕𝒚-𝒇𝒊𝒗𝒆 𝒚𝒆𝒂𝒓𝒔 𝒂𝒈𝒐, 𝒎𝒆𝒅𝒕𝒆𝒄𝒉 𝒊𝒏𝒏𝒐𝒗𝒂𝒕𝒊𝒐𝒏 𝒎𝒆𝒂𝒏𝒕 𝒃𝒖𝒍𝒌𝒚 𝒑𝒓𝒐𝒕𝒐𝒕𝒚𝒑𝒆𝒔 𝒂𝒏𝒅 𝒎𝒐𝒏𝒕𝒉𝒔-𝒍𝒐𝒏𝒈 𝒃𝒓𝒆𝒂𝒌𝒕𝒉𝒓𝒐𝒖𝒈𝒉𝒔. 𝑻𝒐𝒅𝒂𝒚, 𝒘𝒆’𝒓𝒆 𝒕𝒂𝒍𝒌𝒊𝒏𝒈 𝒂𝒃𝒐𝒖𝒕 𝒑𝒓𝒐𝒅𝒖𝒄𝒕𝒊𝒐𝒏-𝒓𝒆𝒂𝒅𝒚, 𝑨𝑰-𝒂𝒖𝒈𝒎𝒆𝒏𝒕𝒆𝒅 𝒅𝒆𝒗𝒊𝒄𝒆𝒔 𝒕𝒉𝒂𝒕 𝒇𝒊𝒕 𝒊𝒏 𝒚𝒐𝒖𝒓 𝒉𝒂𝒏𝒅.” A highlight for Pilotfish was 🎤 Harm Hogenbirk’s talk in the 𝐒𝐦𝐚𝐫𝐭 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 section of the Symposium. He shared how 𝐇𝐮𝐦𝐚𝐧 𝐅𝐚𝐜𝐭𝐨𝐫𝐬 𝐄𝐧𝐠𝐢𝐧𝐞𝐞𝐫𝐢𝐧𝐠 guided the development of EP Solutions’ non-invasive cardiac mapping system, from early usability testing with nurses and doctors to design choices that cut application time to under ten minutes and improved consistency. Reflecting on the event, Harm said: “𝑻𝒉𝒊𝒔 𝒚𝒆𝒂𝒓’𝒔 𝒆𝒙𝒑𝒐 𝒔𝒉𝒐𝒘𝒆𝒅 𝒉𝒐𝒘 𝒇𝒂𝒓 𝑴𝒆𝒅𝑻𝒆𝒄𝒉 𝒉𝒂𝒔 𝒄𝒐𝒎𝒆 𝒊𝒏 𝒄𝒐𝒎𝒃𝒊𝒏𝒊𝒏𝒈 𝒖𝒔𝒂𝒃𝒊𝒍𝒊𝒕𝒚 𝒂𝒏𝒅 𝒕𝒆𝒄𝒉𝒏𝒐𝒍𝒐𝒈𝒚. 𝑻𝒉𝒆 𝒄𝒐𝒏𝒗𝒆𝒓𝒔𝒂𝒕𝒊𝒐𝒏𝒔 𝒘𝒆𝒓𝒆 𝒂𝒃𝒐𝒖𝒕 𝒄𝒍𝒊𝒏𝒊𝒄𝒂𝒍 𝒘𝒐𝒓𝒌𝒇𝒍𝒐𝒘𝒔, 𝒑𝒂𝒕𝒊𝒆𝒏𝒕 𝒆𝒙𝒑𝒆𝒓𝒊𝒆𝒏𝒄𝒆, 𝒂𝒏𝒅 𝒓𝒆𝒂𝒍-𝒘𝒐𝒓𝒍𝒅 𝒑𝒆𝒓𝒇𝒐𝒓𝒎𝒂𝒏𝒄𝒆, 𝒆𝒙𝒂𝒄𝒕𝒍𝒚 𝒘𝒉𝒆𝒓𝒆 𝒊𝒏𝒏𝒐𝒗𝒂𝒕𝒊𝒐𝒏 𝒏𝒆𝒆𝒅𝒔 𝒕𝒐 𝒃𝒆.” 💡 Pilotfish and Zign Group are continuing the conversations that started in Luzern. If you would like to explore how integrated design, Human Factors Engineering, and manufacturing can accelerate your next medical device project, reach out via https://lnkd.in/eeksRc5z #SwissMedTechExpo #MedTech #HumanFactors #AdditiveManufacturing #AIinHealthcare #Miniaturization #Pilotfish #ZignGroup

Europe Medical Devices Market: Heading Toward a USD 197.5B Milestone! A recent in-depth market forecast shows the Europe Medical Devices Market is expected to expand from USD 136,457 Million (2023) to USD 197,538 Million by 2030, at a robust 5.6% CAGR. Here’s what’s shaping the roadmap: ▸ Demographic tailwinds: Europe’s aging population is fueling demand for diagnostics, implants, and chronic disease management devices.  ▸ Tech transformation: Smart sensors, AI in diagnostics, remote patient monitoring, and robotics are redefining standards.  ▸ Regulatory impact: The new EU MDR and IVDR frameworks are elevating safety and compliance across the value chain.  ▸ Eco & circular design: Green manufacturing, reusability, and energy efficiency are becoming key differentiators. The message is clear: innovation + compliance + sustainability = success. We’re ready to help partners seize these opportunities meaningfully. Let’s collaborate whether you’re a medtech brand, investor, or stakeholder looking at Europe. Reach out to explore strategic pathways. 🔗 Explore the complete report here: https://lnkd.in/depXcrHs 🔗 Read the full Press Release here: https://lnkd.in/dwr66Gkt #EuropeMedicalDevicesMarket #HealthcareInnovation #MedTech #Diagnostics #DigitalHealth #MedicalDevices #HealthTech #RegulatoryExcellence #Sustainability #InvestmentInsights #MedicalDeviceTrends #FutureOfHealthcare #MedTechGrowth #HealthcareStrategy #Diagnostics #RegulatoryCompliance #SmartHealth #SustainableHealthTech #MedicalDevicesGrowth #DigitalDiagnostics #InnovationInHealthcare #InvestmentOpportunities #FutureMedTech #MarkAndSparkSolutions

Excited to participate in the Photonic Innovation in the MedTech Symposium 2025 hosted at University College Cork, Ireland 🇮🇪 by Tyndall National Institute. This event is part of the PhotonMed activity and MedPhab association, which bring together experts and innovators across Europe to accelerate the development of photonics-based medical devices. ⭐️The symposium has highlighted how advancing photonic component and manufacturing technologies is powering the next generation of optical medical devices. ⭐️By building pilot lines and demonstrating integrated technologies in real-world cases, our community is making diagnostics and monitoring more accessible, accurate, and personalized. ⭐️Photonics drives healthcare innovation by linking robust R&D with scalable ISO13485-compatible manufacturing and a dynamic ecosystem for medical device development. Looking forward to future PhotonMed activities and continued innovation with CSEM !🚀

𝐈𝐧𝐟𝐮𝐬𝐢𝐨𝐧 𝐏𝐮𝐦𝐩 𝐌𝐚𝐫𝐤𝐞𝐭 𝟐𝟎𝟐𝟓: 𝐀𝐝𝐯𝐚𝐧𝐜𝐢𝐧𝐠 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐂𝐚𝐫𝐞 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐒𝐦𝐚𝐫𝐭 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 🔗 𝐀𝐜𝐜𝐞𝐬𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭: https://lnkd.in/d2M2RwcU The Infusion Pump Market in 2025 continues to evolve with technological breakthroughs in precision drug delivery, connectivity, and patient safety. Increasing demand for home healthcare devices, coupled with the integration of IoT and AI-based monitoring, is reshaping treatment efficiency and reliability across hospitals and clinics worldwide. From 2026 to 2032, the market is expected to experience strong growth, supported by the rising prevalence of chronic diseases, growing geriatric populations, and the shift toward value-based healthcare systems. Smart infusion pumps, wireless connectivity, and real-time data analytics will remain key enablers for improving patient outcomes and reducing medication errors. 𝐊𝐞𝐲-𝐩𝐥𝐚𝐲𝐞𝐫𝐬: Baxter International Inc. | B. Braun Group | BD | Fresenius Kabi | ICU Medical | Smiths Medical | Terumo Neuro | Medtronic | Moog Inc. | Zyno | Micrel Medical Devices | Ypsomed AG | CODAN Medical AG | Hospira | KORU Medical Systems | NIPRO Corporation - Global | Mindray | Q Core Medical Ltd. | Viatris | ATOM Medical USA | Valeritas | Trivitron Healthcare #InfusionPump #MedicalDevices #HealthcareTechnology #DrugDelivery #SmartInfusion #IoTInHealthcare #PatientSafety #DigitalHealth #HospitalEquipment #BiomedicalEngineering #HealthTech #MedicalInnovation #ClinicalCare #InfusionTherapy #AIInHealthcare #ChronicDiseaseManagement #ConnectedDevices #HealthcareAutomation #SmartHospitals #MedicalEquipment #HealthcareSolutions #MedicalTechnology #PrecisionMedicine #HomeHealthcare #PharmaTechnology

Smarter, Smaller, More Human (Boston Scientific to acquire Nalu Medical) It’s always exciting to see major progress that benefits patients and validates years of innovation in our field. The future is focal. Congratulations to the teams at Nalu Medical, Inc. and Boston Scientific on agreement to acquire Nalu, a milestone that highlights both companies’ leadership and the accelerating transformation of bioelectronic medicine. This news also reflects the growing trend of developing Intelligent Focal Technologies (IFT) — the convergence of wireless power, data intelligence, and targeted therapy delivery that’s reshaping what’s possible for implantable devices. IFT isn’t a single technology but a movement toward systems that are smaller, smarter, and more attuned to the patient, bringing us closer to therapies that are as dynamic as the bodies they serve. #Medtech #Bioelectronics #Neuromodulation #IntelligentFocalTechnologies #PatientImpact #Innovation

When demand for life-changing medical tech rises, efficiency and innovation aren’t optional, they’re essential. That’s why Dexcom, a leader in continuous glucose monitoring, turned to Siemens Plant Simulation to optimize operations and keep pushing boundaries. From virtual factory planning to eliminating bottlenecks and even improving on-site safety, simulation helps Dexcom deliver smaller, smarter, and more accessible devices—without slowing down. Innovation isn’t just in the product; it’s in the process. 💡 #HealthcareInnovation #SiemensAdvanta #DigitalTwin By embedding simulation into daily decision-making, Dexcom is scaling operations, maintaining affordability, and supporting their mission to improve the lives of people with diabetes worldwide: https://sie.ag/6Qon3F

🧬 Emerging Point-of-Care (POC) Techniques in Clinical Science Point-of-Care (POC) testing is revolutionizing modern diagnostics by bringing laboratory precision to the patient’s bedside. From glucose monitoring to CRISPR-based molecular assays, POC technologies are transforming clinical decision-making, patient management, and healthcare accessibility. ⚙️ Key Innovations in POC Diagnostics: 1️⃣ Microfluidic Lab-on-a-Chip Systems – Perform rapid, multi-step analyses with minimal sample volume. 2️⃣ Biosensor-Based Devices – Use biological recognition elements for real-time biomarker detection. 3️⃣ Molecular POC Testing – Enables rapid pathogen identification using isothermal amplification and CRISPR tools. 4️⃣ Smartphone-Integrated Platforms – Allow instant data sharing and telemedicine support. 5️⃣ Wearable Biosensors – Facilitate continuous monitoring for chronic disease management. 🌍 Why It Matters: POC testing enhances speed, accuracy, and accessibility — key to strengthening clinical response in emergencies, infectious disease surveillance, and personalized medicine. 💡 The next frontier integrates AI, automation, and digital health ecosystems, making diagnostics faster, smarter, and more predictive than ever. #PointOfCareTesting #ClinicalDiagnostics #POCTechnology #MolecularDiagnostics #Microfluidics #Biosensors #CRISPRDiagnostics #WearableTech #DigitalHealth #ArtificialIntelligence #HealthcareInnovation #BiomedicalEngineering #PrecisionMedicine #ClinicalGenomics #Telemedicine #ResearchInnovation #MedicalTechnology #Bioinformatics #ApnaBiotech #NextGenDiagnostics

🧠 Earlier this month, Leuven-based icometrix announced its 𝐚𝐜𝐪𝐮𝐢𝐬𝐢𝐭𝐢𝐨𝐧 by GE HealthCare, marking a 𝐦𝐚𝐣𝐨𝐫 𝐦𝐢𝐥𝐞𝐬𝐭𝐨𝐧𝐞 𝐟𝐨𝐫 𝐅𝐥𝐞𝐦𝐢𝐬𝐡 𝐡𝐞𝐚𝐥𝐭𝐡𝐭𝐞𝐜𝐡! Known for its AI-powered icobrain platform, icometrix provides 𝐚𝐝𝐯𝐚𝐧𝐜𝐞𝐝 𝐛𝐫𝐚𝐢𝐧 𝐌𝐑𝐈 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐭𝐨𝐨𝐥𝐬 that support clinicians in diagnosing and monitoring neurological conditions like Alzheimer’s, MS and stroke. 🧠 The integration of icobrain into GE HealthCare’s MRI systems will help scale precision care globally, offering faster, more accurate insights for treatment planning. It’s a powerful example of how Flemish innovation is driving the future of healthcare, combining deep tech with clinical impact, and now reaching patients worldwide. 🧠 This is a proud moment for Flanders’ healthtech ecosystem, and a clear signal to UK investors and partners: 𝑭𝒍𝒆𝒎𝒊𝒔𝒉 𝒊𝒏𝒏𝒐𝒗𝒂𝒕𝒊𝒐𝒏 𝒊𝒔 𝒔𝒉𝒂𝒑𝒊𝒏𝒈 𝒕𝒉𝒆 𝒇𝒖𝒕𝒖𝒓𝒆 𝒐𝒇 𝒈𝒍𝒐𝒃𝒂𝒍 𝒉𝒆𝒂𝒍𝒕𝒉𝒄𝒂𝒓𝒆. 🔗 GE HealthCare: https://lnkd.in/eChMYhQ6